Trial Outcomes & Findings for Functional Electrical Stimulation (FES) Driven Stepping in Individuals With Spinal Cord Injury (NCT NCT01479777)
NCT ID: NCT01479777
Last Updated: 2014-09-15
Results Overview
Change in motor, pin prick, and light touch score components of the ASIA Impairment scale (AIS) after 8 weeks of stepping FES in persons with spinal cord injury. The AIS evaluates motor and sensory function and comprises motor (min 0, max 100), pin prick (min 0, max 112), and light touch (min 0, max 112) scores. Higher scores represent better functional outcome. AIS Classificatrion: A = Complete: No motor or sensory function is preserved in the sacral segments S4-S5. B = Incomplete: Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5. C = Incomplete: Motor function is preserved below the neurological level, and more than half of key muscles below the neurological level have a muscle grade less than 3. D = Incomplete: Motor function is preserved below the neurological level, and at least half of key muscles below the neurological level have a muscle grade of 3 or more. E = Normal: motor and sensory function are normal.
COMPLETED
PHASE1/PHASE2
12 participants
Baseline, 8 weeks
2014-09-15
Participant Flow
Participant milestones
| Measure |
FES Stepping
For the next 8 weeks, we will ask you to come to the ICSCI twice (2) time per week during which you will perform FES Stepping.
|
|---|---|
|
Overall Study
STARTED
|
12
|
|
Overall Study
COMPLETED
|
10
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
| Measure |
FES Stepping
For the next 8 weeks, we will ask you to come to the ICSCI twice (2) time per week during which you will perform FES Stepping.
|
|---|---|
|
Overall Study
Physician Decision
|
2
|
Baseline Characteristics
Functional Electrical Stimulation (FES) Driven Stepping in Individuals With Spinal Cord Injury
Baseline characteristics by cohort
| Measure |
FES Stepping
n=12 Participants
FES Stepping, twice a week, for 8 weeks.
|
|---|---|
|
Age, Continuous
|
37 years
STANDARD_DEVIATION 15 • n=5 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline, 8 weeksChange in motor, pin prick, and light touch score components of the ASIA Impairment scale (AIS) after 8 weeks of stepping FES in persons with spinal cord injury. The AIS evaluates motor and sensory function and comprises motor (min 0, max 100), pin prick (min 0, max 112), and light touch (min 0, max 112) scores. Higher scores represent better functional outcome. AIS Classificatrion: A = Complete: No motor or sensory function is preserved in the sacral segments S4-S5. B = Incomplete: Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5. C = Incomplete: Motor function is preserved below the neurological level, and more than half of key muscles below the neurological level have a muscle grade less than 3. D = Incomplete: Motor function is preserved below the neurological level, and at least half of key muscles below the neurological level have a muscle grade of 3 or more. E = Normal: motor and sensory function are normal.
Outcome measures
| Measure |
FES Stepping
n=10 Participants
FES Stepping, twice a week, for 8 weeks.
|
|---|---|
|
Change in Motor and Sensory Scores of the ASIA Impairment Scale (AIS)
Upper Extremity Motor Score
|
1.0 scores on AIS Scale
Interval 0.0 to 5.0
|
|
Change in Motor and Sensory Scores of the ASIA Impairment Scale (AIS)
Lower Extremity Motor Score
|
2.7 scores on AIS Scale
Interval -1.0 to 7.0
|
|
Change in Motor and Sensory Scores of the ASIA Impairment Scale (AIS)
Light Touch
|
2.4 scores on AIS Scale
Interval -2.0 to 9.0
|
|
Change in Motor and Sensory Scores of the ASIA Impairment Scale (AIS)
Pin prick
|
-1.2 scores on AIS Scale
Interval -16.0 to 11.0
|
SECONDARY outcome
Timeframe: Baseline, 8 weeksChange in heart rate following 8 weeks of FES. Change in heart rate from baseline was computed from week 8 parameters.
Outcome measures
| Measure |
FES Stepping
n=10 Participants
FES Stepping, twice a week, for 8 weeks.
|
|---|---|
|
Change in Heart Rate
|
-3.3 beats per minute
Interval -18.0 to 6.0
|
SECONDARY outcome
Timeframe: Baseline, 8 weeksChange in systolic blood pressure following 8 weeks. Change in systolic blood pressure from baseline was computed from week 8 parameters.
Outcome measures
| Measure |
FES Stepping
n=10 Participants
FES Stepping, twice a week, for 8 weeks.
|
|---|---|
|
Change in Systolic Blood Pressure
|
1.1 mmHg
Interval -24.0 to 23.0
|
SECONDARY outcome
Timeframe: Baseline, 8 weeksChange in distolic blood pressure following 8 weeks. Change in diastolic blood pressure from baseline was computed from week 8 parameters.
Outcome measures
| Measure |
FES Stepping
n=10 Participants
FES Stepping, twice a week, for 8 weeks.
|
|---|---|
|
Change in Diastolic Plood Pressure
|
1.8 mmHg
Interval -14.0 to 22.0
|
SECONDARY outcome
Timeframe: Baseline, 8 weeksChange in rate of perceived exertion (RPE) following 8 weeks of FES. Change in rate of perceived exertion (RPE) from baseline was computed from week 8 parameters. The RPE scale is a 15 point scale ranging from 6 to 20 points. Higher scores indicate greater exertion.
Outcome measures
| Measure |
FES Stepping
n=10 Participants
FES Stepping, twice a week, for 8 weeks.
|
|---|---|
|
Change in Rate of Perceived Exertion
|
-0.64 scores on RPE scale
Interval -3.0 to 1.0
|
SECONDARY outcome
Timeframe: Baseline, 8 weeksChange in vital capacity following 8 weeks of FES. Change in vital capacity from baseline was computed from week 8 parameters.
Outcome measures
| Measure |
FES Stepping
n=10 Participants
FES Stepping, twice a week, for 8 weeks.
|
|---|---|
|
Change in Vital Capacity
|
-0.29 litres
Interval -0.97 to 0.56
|
SECONDARY outcome
Timeframe: Baseline, 8 weeksChange in cough flow following 8 weeks of FES. Change in peak cough flow from baseline was computed from week 8 parameters.
Outcome measures
| Measure |
FES Stepping
n=10 Participants
FES Stepping, twice a week, for 8 weeks.
|
|---|---|
|
Change in Peak Cough Flow
|
-6 liters/minute
Interval -110.0 to 100.0
|
Adverse Events
FES Stepping
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
FES Stepping
n=12 participants at risk
FES Stepping, twice a week, for 8 weeks.
|
|---|---|
|
Musculoskeletal and connective tissue disorders
Ankle Swelling (X-ray negative for bone fracture or dislocation)
|
16.7%
2/12 • Number of events 2
|
|
Cardiac disorders
Lightheadedness
|
25.0%
3/12 • Number of events 3
|
|
Musculoskeletal and connective tissue disorders
Increased tone in lower extremity
|
25.0%
3/12 • Number of events 3
|
Additional Information
Dr. Cristina Sadowsky
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place